{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017152","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.607318+00:00","generated_at":"2026-05-18T12:14:24.117177+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cyclacel shareholders reelect directors, approve equity plan increase, endorse executive pay","bullets":["Re-elected all five director nominees with over 99.97% support each.","Approved amendment to 2018 Equity Incentive Plan increasing share reserve by 4,281,987 shares (99.94% votes for).","Advisory vote on executive compensation passed with 99.95% votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017152","json":"https://secwatch.observer/filing/0001641172-25-017152.json","markdown":"https://secwatch.observer/filing/0001641172-25-017152.md","text":"https://secwatch.observer/filing/0001641172-25-017152.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225017152/0001641172-25-017152-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225017152/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T12:14:24.117177+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}